vs
ACADIA PHARMACEUTICALS INC(ACAD)与POWER SOLUTIONS INTERNATIONAL, INC.(PSIX)财务数据对比。点击上方公司名可切换其他公司
ACADIA PHARMACEUTICALS INC的季度营收约是POWER SOLUTIONS INTERNATIONAL, INC.的1.4倍($268.1M vs $191.2M),POWER SOLUTIONS INTERNATIONAL, INC.净利率更高(8.4% vs 1.4%,领先7.1%),POWER SOLUTIONS INTERNATIONAL, INC.同比增速更快(32.5% vs 9.7%),过去两年POWER SOLUTIONS INTERNATIONAL, INC.的营收复合增速更高(41.7% vs 5.3%)
阿卡迪亚制药是一家总部位于美国加利福尼亚州圣地亚哥德尔马地区的生物制药企业,专注于中枢神经系统相关疾病治疗药物的研发、生产与商业化,致力于为全球患者提供创新的临床治疗方案。
阿达尼能源解决方案有限公司(前身为阿达尼输电有限公司)是一家电力输配企业,总部位于艾哈迈达巴德。截至2025年4月,公司累计输电网络总长26696回路公里,是印度规模最大的民营输电企业之一。
ACAD vs PSIX — 直观对比
营收规模更大
ACAD
是对方的1.4倍
$191.2M
营收增速更快
PSIX
高出22.8%
9.7%
净利率更高
PSIX
高出7.1%
1.4%
两年增速更快
PSIX
近两年复合增速
5.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $268.1M | $191.2M |
| 净利润 | $3.6M | $16.1M |
| 毛利率 | — | 21.9% |
| 营业利润率 | -1.7% | 12.7% |
| 净利率 | 1.4% | 8.4% |
| 营收同比 | 9.7% | 32.5% |
| 净利润同比 | — | -31.0% |
| 每股收益(稀释后) | $0.02 | $0.69 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACAD
PSIX
| Q1 26 | $268.1M | — | ||
| Q4 25 | $284.0M | $191.2M | ||
| Q3 25 | $278.6M | $203.8M | ||
| Q2 25 | $264.6M | $191.9M | ||
| Q1 25 | $244.3M | $135.4M | ||
| Q4 24 | $259.6M | $144.3M | ||
| Q3 24 | $250.4M | $125.8M | ||
| Q2 24 | $242.0M | $110.6M |
净利润
ACAD
PSIX
| Q1 26 | $3.6M | — | ||
| Q4 25 | $273.6M | $16.1M | ||
| Q3 25 | $71.8M | $27.6M | ||
| Q2 25 | $26.7M | $51.2M | ||
| Q1 25 | $19.0M | $19.1M | ||
| Q4 24 | $143.7M | $23.3M | ||
| Q3 24 | $32.8M | $17.3M | ||
| Q2 24 | $33.4M | $21.5M |
毛利率
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | 21.9% | ||
| Q3 25 | 92.2% | 23.9% | ||
| Q2 25 | 92.2% | 28.2% | ||
| Q1 25 | 91.7% | 29.7% | ||
| Q4 24 | 91.6% | 29.9% | ||
| Q3 24 | 92.5% | 28.9% | ||
| Q2 24 | 92.5% | 31.8% |
营业利润率
ACAD
PSIX
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 12.7% | ||
| Q3 25 | 12.8% | 13.9% | ||
| Q2 25 | 12.2% | 16.9% | ||
| Q1 25 | 7.9% | 18.2% | ||
| Q4 24 | 59.1% | 17.5% | ||
| Q3 24 | 12.6% | 16.3% | ||
| Q2 24 | 12.6% | 22.9% |
净利率
ACAD
PSIX
| Q1 26 | 1.4% | — | ||
| Q4 25 | 96.3% | 8.4% | ||
| Q3 25 | 25.8% | 13.5% | ||
| Q2 25 | 10.1% | 26.7% | ||
| Q1 25 | 7.8% | 14.1% | ||
| Q4 24 | 55.4% | 16.1% | ||
| Q3 24 | 13.1% | 13.8% | ||
| Q2 24 | 13.8% | 19.5% |
每股收益(稀释后)
ACAD
PSIX
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | $0.69 | ||
| Q3 25 | $0.42 | $1.20 | ||
| Q2 25 | $0.16 | $2.22 | ||
| Q1 25 | $0.11 | $0.83 | ||
| Q4 24 | $0.86 | $1.01 | ||
| Q3 24 | $0.20 | $0.75 | ||
| Q2 24 | $0.20 | $0.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $41.3M |
| 总债务越低越好 | — | $96.6M |
| 股东权益账面价值 | — | $178.6M |
| 总资产 | $1.6B | $424.7M |
| 负债/权益比越低杠杆越低 | — | 0.54× |
8季度趋势,按日历期对齐
现金及短期投资
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | $41.3M | ||
| Q3 25 | $258.0M | $49.0M | ||
| Q2 25 | $253.6M | $49.5M | ||
| Q1 25 | $217.7M | $50.0M | ||
| Q4 24 | $319.6M | $55.3M | ||
| Q3 24 | $155.1M | $40.5M | ||
| Q2 24 | $177.1M | $28.8M |
总债务
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | — | $96.6M | ||
| Q3 25 | — | $96.7M | ||
| Q2 25 | — | $1.8M | ||
| Q1 25 | — | $1.0M | ||
| Q4 24 | — | $184.0K | ||
| Q3 24 | — | $238.0K | ||
| Q2 24 | — | $292.0K |
股东权益
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $178.6M | ||
| Q3 25 | $917.3M | $162.5M | ||
| Q2 25 | $822.4M | $135.7M | ||
| Q1 25 | $765.2M | $84.3M | ||
| Q4 24 | $732.8M | $65.3M | ||
| Q3 24 | $577.2M | $42.1M | ||
| Q2 24 | $516.7M | $24.8M |
总资产
ACAD
PSIX
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $424.7M | ||
| Q3 25 | $1.3B | $458.9M | ||
| Q2 25 | $1.2B | $437.7M | ||
| Q1 25 | $1.1B | $372.7M | ||
| Q4 24 | $1.2B | $328.2M | ||
| Q3 24 | $976.9M | $339.1M | ||
| Q2 24 | $914.1M | $307.6M |
负债/权益比
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.54× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-4.6M |
| 自由现金流经营现金流 - 资本支出 | — | $-7.6M |
| 自由现金流率自由现金流/营收 | — | -4.0% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.29× |
| 过去12个月自由现金流最近4个季度 | — | $14.1M |
8季度趋势,按日历期对齐
经营现金流
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $-4.6M | ||
| Q3 25 | $74.3M | $3.3M | ||
| Q2 25 | $64.0M | $16.7M | ||
| Q1 25 | $20.3M | $8.8M | ||
| Q4 24 | $40.4M | $32.7M | ||
| Q3 24 | $63.2M | $12.6M | ||
| Q2 24 | $25.0M | $1.5M |
自由现金流
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | — | $-7.6M | ||
| Q3 25 | $73.9M | $1.7M | ||
| Q2 25 | — | $14.6M | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $30.0M | ||
| Q3 24 | $63.2M | $12.1M | ||
| Q2 24 | — | $822.0K |
自由现金流率
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | — | -4.0% | ||
| Q3 25 | 26.5% | 0.8% | ||
| Q2 25 | — | 7.6% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | 25.2% | 9.7% | ||
| Q2 24 | — | 0.7% |
资本支出强度
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | 0.1% | 0.8% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | — | 0.6% |
现金转化率
ACAD
PSIX
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | -0.29× | ||
| Q3 25 | 1.03× | 0.12× | ||
| Q2 25 | 2.40× | 0.33× | ||
| Q1 25 | 1.07× | 0.46× | ||
| Q4 24 | 0.28× | 1.40× | ||
| Q3 24 | 1.93× | 0.73× | ||
| Q2 24 | 0.75× | 0.07× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACAD
暂无分部数据
PSIX
| Energy End Market | $153.4M | 80% |
| Industrial End Market | $33.3M | 17% |
| Transportation End Market | $4.6M | 2% |